“…Populations, genetic assessment, and outcomes Seventeen of the 22 included studies (72.3%) were conducted in Northern Africa (7 in Egypt, 8 in Tunisia and 2 in Morocco) (Abd El-Aziz et al, 2011Abdel Ghany et al, 2017;Abdel-Hamed et al, 2017;Bennouar et al, 2004;Boghdady et al, 2016;Elouej et al, 2016aElouej et al, , 2016bElouej et al, , 2016cFekih et al, 2014;Kefi et al, 2017;Khella et al, 2017;Mehri et al, 2010;Morjane et al, 2017;Sediri et al, 2011;Sellami et al, 2018), whereas only 5 were performed in sub-Saharan African populations (1 in Zimbabweans, 1 in Nigerians, and 3 in South Africans) (Ellman et al, 2015;Engwa et al, 2018;Hooper et al, 2007;Kodogo et al, 2016;Masemola et al, 2007). Most studies were conducted among patients with coronary artery disease, diabetes mellitus, or metabolic syndrome.…”